ABSTRACT. The mechanisms by which bilirubin causes neurotoxicity in newborns have not been well defined, but an involvement in synaptic transmission appears possible. Herein we present evidence for an inhibitory effect of bilirubin on both basal and depolarization-induced (50 mM KCl) phosphorylation of synapsin I, a synaptic vesicleassociated protein that may play a role in neurotransmitter release. Synaptosomes from rat cerebral cortices, prelabeled with 32P in vitro to label the intraterminal ATP pool, were incubated with or without bilirubin and bovine serum albumin (added as a stabilizer) at varying doses and for different time intervals. Some preparations were also depolarized by high KC1 concentrations to induce Ca++ influx. The phosphorylation of synapsin I was monitored. Our results show that addition of bilirubin to the medium significantly decreases 32P incorporation into synapsin I, both under basal and depolarizing conditions, in a timeand dose-dependent manner, significant effects being observed already at 10 pM bilirubin after 120-min incubation of the synaptosomes. Separate analysis of the multiple phosphorylation sites in synapsin I showed that the phosphorylation of both the "head" and "tail" regions of the protein was decreased by bilirubin. Removal of the bilirubin-containing incubation medium retarded the decrease in synapsin I 32P content, indicating that the effect observed may be reversible. The nontoxic pyrrole biliverdin had no effect on synapsin I phosphorylation under the experimental conditions used, indicating that the effect was specific to bilirubin. Our results thus suggest that bilirubin may achieve some of its reversible effects on the brain through inhibition of the phosphorylation of the synapsic vesicleassociated protein synapsin I. (Pediatr Res 23: 219-223, 1988) 
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Recent studies have implicated protein phosphorylation as an important regulatory mechanism in the function of nerve cells (7) . Stimulation-dependent release of neurotransmitters appears to be one phenomenon that is regulated by phosphorylation of specific intraterminal proteins (cf. Ref. 8 for review). Synapsin I, a neuron-protein known to be specifically associated with synaptic vesicles (9) , may be involved in this regulation. Thus, intracellular injection studies have indicated that the dephosphorylated form of synapsin I may inhibit the release process, while phosphorylation of synapsin I, catalyzed by Ca/calmodulindependent kinase 11, appears to promote stimulation-dependent neurotransmitter release (10) .
We considered the possibility that part of the depressive effect of bilirubin on central nervous system function might be due to effects on nerve terminal function. We therefore found it of interest to investigate whether bilirubin would interfere with the protein phosphorylation systems involved in synapsin I phosphorylation in intact nerve terminals, where the protein is known to be associated with the cytosolic surface of synaptic vesicles (9) . For this purpose we decided to use an intact synaptosomal preparation, enriched in viable nerve terminals, in which prelabeling with inorganic 32P leads to labeling of the nerve terminal ATP pool (1 1). In this preparation it is possible to analyze whether phosphate incorporation into synapsin I under basal and depolarized conditions may be influenced by bilirubin. A summary of some of the results has been presented previously (1 2). Other chemicals, of reagent grade, were obtained from standard commercial suppliers.
METHODS
Animals. Male Sprague-Dawley rats (200-300 g) were used in all experiments. They were stunned and decapitated, and the cortices were dissected out on a cold surface before being placed in ice-cold 0.32 M sucrose.
Preparation of synaptosomes. Each cortex was homogenized in glass-Teflon homogenizers in 25 ml of ice-cold 0.32 M sucrose, and a crude synaptosomal fraction was prepared by differential centrifugation (13). The synaptosome preparation was then resuspended in 6-8 ml of an oxygenated Krebs Ringer buffer (pH 7.4) containing (mM): NaCl 132, MgS04 2.4, KC1 4.8, Hepes 20, CaC1, 1, glucose 10.
Prelabeling of endogenous ATP-pool. A total of 37 MBq of 32P, was added to 3 ml of the synaptosome suspension, which was then incubated at 37" C for 30 min (1 1). After this the synaptosomes were centrifuged at 2000 rpm for 5 min, the highly radioactive supernatant decanted, and the synaptosomes resuspended in 3.2 ml of Krebs Ringer buffer.
Incubation with bilirubin and BSA. Bilirubin, dissolved in 0.1 N NaOH and stabilized by the addition of BSA in a molar ratio of 1:10 (BSA:bilirubin), was diluted with Krebs Ringer buffer such that addition of 10 of the bilirubin/BSA solution to 100 pl of the synaptosome suspension resulted in bilirubin concentrations of 1 -160 pM in the final incubate. A BSA concentrate treated similarly was used for the control incubations. During preparation and incubation the bilirubin/BSA-containing solutions were covered by aluminum foil and shielded from light as much as possible.
After the addition of bilirubin and/or BSA, the synaptosome suspensions were incubated for periods of 15, 60, and 120 min, after which the reaction was stopped by adding 50 p1 of a SDScontaining "stop solution" (14) , followed by boiling for 2 min.
Some incubates were depolarized for 30 s by the addition of a concentrated solution of KC1 (final c~ncentration 50 mM) before adding SDS-solution and boiling as described above.
Analysis of synapsin I phosphorylation. The phosphorylated proteins were separated by one-dimensional SDS-PAGE using gels containing 8% acrylamide (15) . After removal of the dyefront and brief washing in 10% isopropanol/ 10% acetic acid in water, the gels were dried and subjected to autoradiography. Synapsin I was identified on the gels as a doublet of 80186 kD molecular mass, cut out from the gel, and the radioactivity incorporated was measured by liquid scintillation counting of the gel pieces (1 6) .
Analysis of multiple site phosphorylution by peptide mapping. In order to analyze the site-specific phosphorylation of the different domains of synapsin I, the gel pieces containing synapsin I were subjected to incomplete proteolytic digestion using S. aureus V8 protease (1 7). The radioactive peptide fragments were separated by SDS-PAGE on 15 % acrylamide gels, visualized by autoradiography of the dried gels and quantitated by liquid scintillation counting as described above.
RESULTS
An initial series of experiments suggested that bilirubin could induce a decrease in the 32P content of synapsin I in the rat cerebral cortex synaptosome preparation, when analyzed by onedimensional SDS-PAGE (Fig. I) . This phenomenon was therefore studied further.
After 30 min of prelabeling, which has been found to be suitable for nerve terminal labeling in this type of experiment (1 I), and removal of extrasynaptosomal 32P,, exposure to bilirubin for 120 min led to a distinct decrease in the 32P content of phosphoproteins in the molecular mass range of 80186 kD, which mostly represent synapsin I. When compared to control incubates, this decrease in phosphate incorporation was significant at bilirubin concentrations as low as 10 pM (Fig. 2) . The decrease BASAL C B B C C B B stopping the reaction (Fig. 3B) . BSA alone had no significant effect on synapsin I phosphorylation. Identical experiments with biliverdin, a chemically related pyrrole compound differing from bilirubin in the absence of a hydrogen atom and the corresponding presence of a double binding at the r position of the molecule, did not lead to chances in the phospho.$ation of synapsin I (data not shown).
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Inasmuch as the 80186 kD reeion of 1-dimensional SDS-PAGE gels derived fro& synapto~omes also contains proteins other than synapsin I (18), and because synapsin I can be phosphorylated on more than one site (17, 19) , we decided to specifically analyze the effect of bilirubin on the distinct sites of phosphorylation of the synapsin I molecule. To this end we used the incomplete proteolytic digestion technique developed by Cleveland et al. (20) . This technique, when using the S. aureus V8 protease, separates site 11, which is phosphorylated by Ca/ calmodulin-dependent kinase I1 and is located in the "tail region" of the molecule, from site I, which is phosphorylated by CAMPdependent kinase and Ca/calmodulin-dependent kinase I, and is located in the "head region" of the molecule (17, 21) .
Separate analysis of these phosphorylation sites showed that bilirubin significantly decreased phosphorylation of both sites in a dose-and time-dependent manner. For example, when synaptosomes were exposed to bilirubin 160 pM/BSA 16 fiM, both site I and site I1 phosphorylation were significantly lower than in the controls (p < 0.05), at 60 min (not shown) and 120 min, in the unstimulated and in the KC1-depolarized preparations (Fig.  4) . Significant reductions in unstimulated phosphorylation were observed from bilirubin concentrations of 10 and 5 fimol/liter for site I and 11, respectively, (data not shown).
A final set of experiments was designed to study whether the inhibitory effect of bilirubin on protein phosphorylation was reversible. Synaptosomes were treated with bilirubin/BSA for 60 min, collected by centrifugation, and incubation was then continued for another 60 min, either in bilirubin/BSA or BSA solution. A reference level of phosphorylation was established by incubating synaptosomes for 60 min with BSA alone, without preceding exposure to bilirubin. In these experiments we observed that the rate of decrease of 32P incorporation in bilirubin- treated synaptosomes was reduced on removal of extracellular bilirubin (Fig. 5) . Thus, when bilirubin begins to diffuse out of the nerve terminals, phosphorylation of synapsin I appears to recover. This indicates that the effect of bilirubin is at least partly reversible. DISCUSSION Herein we show that bilirubin exerts an inhibitory effect on the incorporation of radioactive phosphate into the neuronal phosphoprotein synapsin I in rat cortex synaptosomes in vitro.
These results point to several possible targets for bilirubin toxicity in mammalian brain.
First, our data show that the presynaptic terminals are affected by bilirubin. It is well established that synaptosomes, in vitro preparations of "pinched-off" nerve terminals, represent good models for the study of physiological processes in nerve terminals (22, 23) , and as such might be used for bilirubin studies. Adding to this specificity is the highly restricted distribution of synapsin I, which appears highly enriched only in nerve terminals in association with small, clear synaptic vesicles (24j. Recent results, which implicate the phosphorylation of this protein in the regulation of transmitter release (lo), further suggest that bilirubin, inter alia, may interfere with this particular nerve terminal function.
Use of an in vitro preparation, which avoids several problems of in vivo studies on bilirubin toxicity, has also allowed us to partly characterize the bilirubin effect regarding dose response> time dependency, and specificity. The significant effects of micromolar bilirubin (but not biliverdin, its immediate precursor) observed after 1-2 h incubation are in general agreement with the range of brain bilirubin achieved in animal experiments. Thus, moderate hyperbilirubinemia in the young healthy rat gives brain bilirubin concentrations of 2-3 p M (25, 26) , the use 5 . Effect of removal of extracellular bilirubin on synapsin I phosphorylation in rat cerebral cortex synaptosomes. Synaptosomes, prelabeled with 32Pi as described in the text, and incubated with 160 pM bilirubin116 pM BSA for 60 min, were collected by centrifugation and resuspended in fresh buffer containing 16 pM BSA (R) or 160 pM bilirubin116 pM BSA (B). Incubation was continued for another 60 min, after which synapsin I was isolated and 32P incorporation analyzed as described in the text. a, standard buffer composition. b, 50 mM KC1 (final concentration) added 30 s before termination of incubation, to induce Ca++ influx into the nerve terminals. The reference level of phosphorylation (100%) was established by incubating synaptosomes with BSA alone for 60 min without preceding exposure to bilirubin. of a binding competitor can increase brain bilirubin to 10 pM (25), while opening of the blood-brain barrier can give brain bilirubin concentrations in the 50-75 pM range (27) . These values refer to extractions of bilirubin from whole brain. Moreover, regional differences in brain bilirubin concentration have also been demonstrated (28, 29) , and it is possible that differences in bilirubin concentrations between groups of cells may contribute to the observed difference in sensitivity to bilirubin toxicity (30) . Bilirubin enters the brain quite rapidly, and the bilirubin concentration in the brain has been shown to peak 1 h after administration of a bolus dose of bilirubin in animals with opened blood-brain barriers (3 1). Studies using neuroblastoma (N115) cell cultures have shown that uptake of bilirubin in that system, which probably represents a passive process, is concentration dependent, peaks by 3 h, and is relatively insensitive to temperature (32) . The time course observed in our experiments suggests that nerve terminals may be permeated by bilirubin by the same mechanism.
The mechanism by which bilirubin influences synapsin I phosphorylation is not clear. Our studies indicate that several distinct phosphorylation sites on the protein molecule, which are regulated by distinct Ca++-dependent or cyclic AMP-dependent protein kinases, respectively (17, 19) , were affected by bilirubin. This suggests that bilirubin might have a pervasive effect on protein phosphorylation in synaptosomes. Other workers have also suggested that protein phosphorylation systems in the brain might be influenced by bilirubin. Analysis of histone kinase activities in extracts from jaundiced rabbit brains showed the presence of a cyclic AMP-dependent activity that appeared to be unchanged, while a cyclic AMP-independent activity was reported to be bilirubin sensitive (33) . However, the physiological significance of these observations remains uncertain.
Bilirubin inhibits oxidative phosphorylation in vitro (34, 35) , but the results of in vivo experiments are contradictory (36, 37) .
Effects on membrane permeability have also been reported (38) (39) (40) . Several enzymes are inhibited by bilirubin (cf. Ref. 41 for review). Therefore, the effect induced by bilirubin may have multiple causes. However, preliminary in vitro studies using purified preparations of synapsin I and the catalytic subunit of CAMP-dependent kinase (not shown), indicate that bilirubin may have a direct influence on the phosphorylation of synapsin I, independently of the presence of intact cells or respiratory activity. Such effects, together with possible effects on oxidative phosphorylation or membrane transport, may contribute to the results found herein.
Regardless of the mechanism involved, the significant and reproducible decrease of synapsin I phosphorylation shows a novel effect of bilirubin in the nervous system, an effect that may be involved in the regulation of neurotransmitter release. Future studies in this area may be of interest in relation to the clinical syndrome of lethargy and neurophysiological changes in jaundiced newborns.
